share_log
Reuters ·  Mar 24 03:53
Junshi Biosciences Announces Approval of Snda for Toripalimab in Combination With Bevacizumab for 1St-Line Treatment of Advanced Hepatocellular Carcinoma
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 292

Recommended

Write a comment